TABLE 4.
Ceftolozane-tazobactam MIC (μg/ml) by BMD/Etest | Ceftolozane-tazobactam zone diam (mm) |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | |
BMDa | |||||||||||||||
2 | 1 | 1 | 1 | 2 | 4 | 4 | 1 | 1 | |||||||
1 | 1 | 1 | 4 | 11 | 11 | 7 | 5 | 4 | 3 | 1 | |||||
0.5 | 1 | 3 | 3 | 4 | 15 | 28 | 45 | 45 | 21 | 10 | 6 | 1 | |||
≤0.25 | |||||||||||||||
Etestb | |||||||||||||||
2 | 1 | ||||||||||||||
1 | 1 | 4 | 1 | 3 | 2 | 1 | |||||||||
0.5 | 1 | 1 | 1 | 4 | 5 | 10 | 9 | 6 | 1 | 2 | |||||
≤0.25 | 3 | 4 | 19 | 31 | 46 | 45 | 25 | 11 | 7 | 1 |
Ceftolozane MICs in µg/ml as determined by broth microdilution in the presence of 4 µg/ml tazobactam, compared with zone diameters in mm.
Ceftolozane-tazobactam MICs in µg/ml as determined by Etest, compared with zone diameters in mm.